MEDINCELL: Several catalysts and opportunities to create value to come over the next 12 months | BUY | EUR10
MEDINCELL - BUY | EUR10Several catalysts and opportunities to create value to come over the next 12 months
The situation at the end of March is in line with expectations
The reminder of the calendar year has two key catalysts
New projects, new partnerships in perspective
An unchanged FV
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.